CD8A and metastatic melanoma: In an analysis conducted by Tumeh and his work group, it is shown that CD8-positive TILs encountered in the intratumoral population of metastatic melanoma samples were associated with high rates of response to PD-1/PD-L1 treatment, documented by radiographic reduction in secondary tumors [36].